comprehensive -WSS

comprehensive

author：fashion 2025-10-02 14:51:35 - browse：2766

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Astellas still sees hope in its gene therapy after four deaths

focus

WSS

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

David Sabatini, ex

Does good food count as health care? Study aims to find out

Change Healthcare: What is it, why does its cyberattack matter?

He's 19 months old and has one of the world’s rarest diseases

Medicare drug price negotiation continues, as pharma counteroffers

hotspot

comprehensive

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Fetal cell organoids grown from amniotic fluid, study finds

Apple is now the first public company to be valued at $3 trillion

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

The cancer drug shortage isn’t new — and neither are the solutions

Astellas still sees hope in its gene therapy after four deaths

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Heart attack and stroke risk calculators need revising

Stem cell biologist probes earliest stages of human development

explore

Wegovy, Zepbound and weight loss drugs that preserve muscle

Fetal cell organoids grown from amniotic fluid, study finds

The public health thinking behind the CDC’s new Covid guidance

FDA's Woodcock to retire early next year

PBM reforms clear House panel

He's 19 months old and has one of the world’s rarest diseases

knowledge

focus

focus

explore